Abstract
The notion that protein-coding genes are the only biologically significant moieties in the genome is revolutionarized by the discovery of non-coding RNAs. Among them is a group of small non-coding RNAs termed microRNAs (miRNAs) that has recently been brought to the limelight. Their presence in the genome was only realized after the identification of their founders lin-4 and let-7 in C. elegans through genetic screens. To date, several hundreds of microRNAs have been identified. They are single-stranded RNA molecules of ∼21-22 nucleotides long, excised from precursors of ∼70 nucleotides predicted in silico to from imperfect stem-loop structures. Many of these miRNAs are evolutionarily conserved, implicating important biological functions. Emerging data points to an important role of these tiny RNA molecules in regulating gene expression of target RNAs by at least two post-transcriptional mechanisms: binding to imperfect complementary sequence of the 3 untranslated region (3UTR) and repressing translation; and endonucleolytic cleavage by a double-stranded RNA-mediated interference (RNAi) mechanism through base-pairing with perfect or near-perfect complementary sequence. Studies in several miRNAs in plants and animals illustrate that these small riboregulators can play critical roles in developmental timing and spatial control of cell fate decisions, cell proliferation, apoptosis, cell differentiation and cell metabolism. Developmental defects and tumorigenesis can be a consequence of abnormal expression of miRNAs. This review discusses the biological functions, mechanisms of action, biogenesis and regulation of miRNAs, as well as identification of their target genes, highlighting the potential diversity of this novel class of gene regulators.
Keywords: microrna, gene regulation, untranslated region, translation
Current Genomics
Title: MicroRNAs: Tiny but Not Trivial
Volume: 5 Issue: 3
Author(s): Wayne Tam
Affiliation:
Keywords: microrna, gene regulation, untranslated region, translation
Abstract: The notion that protein-coding genes are the only biologically significant moieties in the genome is revolutionarized by the discovery of non-coding RNAs. Among them is a group of small non-coding RNAs termed microRNAs (miRNAs) that has recently been brought to the limelight. Their presence in the genome was only realized after the identification of their founders lin-4 and let-7 in C. elegans through genetic screens. To date, several hundreds of microRNAs have been identified. They are single-stranded RNA molecules of ∼21-22 nucleotides long, excised from precursors of ∼70 nucleotides predicted in silico to from imperfect stem-loop structures. Many of these miRNAs are evolutionarily conserved, implicating important biological functions. Emerging data points to an important role of these tiny RNA molecules in regulating gene expression of target RNAs by at least two post-transcriptional mechanisms: binding to imperfect complementary sequence of the 3 untranslated region (3UTR) and repressing translation; and endonucleolytic cleavage by a double-stranded RNA-mediated interference (RNAi) mechanism through base-pairing with perfect or near-perfect complementary sequence. Studies in several miRNAs in plants and animals illustrate that these small riboregulators can play critical roles in developmental timing and spatial control of cell fate decisions, cell proliferation, apoptosis, cell differentiation and cell metabolism. Developmental defects and tumorigenesis can be a consequence of abnormal expression of miRNAs. This review discusses the biological functions, mechanisms of action, biogenesis and regulation of miRNAs, as well as identification of their target genes, highlighting the potential diversity of this novel class of gene regulators.
Export Options
About this article
Cite this article as:
Tam Wayne, MicroRNAs: Tiny but Not Trivial, Current Genomics 2004; 5 (3) . https://dx.doi.org/10.2174/1389202043349435
DOI https://dx.doi.org/10.2174/1389202043349435 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dynamics of CD86 Expression on Allergic Inflammation - New Insights
Recent Patents on Inflammation & Allergy Drug Discovery Role of BCL-2 Family Proteins in Apoptosis and its Regulation by Nutrients
Current Protein & Peptide Science A Novel Mechanism for Metal-independent Hydroxyl Radical Production by Hydrogen Peroxide and Halogenated Quinones
Mini-Reviews in Organic Chemistry Histone Deacetylase Inhibitors in Cancer Therapy: New Compounds and Clinical Update of Benzamide-Type Agents
Current Topics in Medicinal Chemistry Natural Antioxidants: Therapeutic Prospects for Cancer and Neurological Diseases
Mini-Reviews in Medicinal Chemistry Use of Analogs of Peptide Hormones Conjugated to Cytotoxic Radicals for Chemotherapy Targeted to Receptors on Tumors
Current Drug Delivery Cellular Based Cancer Vaccines: Type 1 Polarization of Dendritic Cells
Current Medicinal Chemistry Pharmacogenetics of Therapy in Inflammatory Bowel Disease Patients
Current Pharmacogenomics Editorial: Brain Imaging and Automatic Analysis in Neurological and Psychiatric Diseases – Part II
CNS & Neurological Disorders - Drug Targets Relaxin-Like Peptides in Neoplastic Lesions
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents RAS/RAF/MEK Inhibitors in Oncology
Current Medicinal Chemistry Molecular Imaging Strategies for In Vivo Tracking of MicroRNAs: A Comprehensive Review
Current Medicinal Chemistry Senescence and Cell Death Pathways and Their Role in Cancer Therapeutic Outcome
Current Medicinal Chemistry Analysis of Missed Diagnosis of Gastric Lipomas by CT
Current Medical Imaging Evidence of Association between Epstein Barr Virus Serum Antibodies with HAs and RI as Biomarkers of Active Rheumatoid Arthritis
Current Biomarkers (Discontinued) Drug Targeting Strategies in Cancer Treatment: An Overview
Mini-Reviews in Medicinal Chemistry Cardiac MRI in Infiltrative Disorders: A Concise Review
Current Cardiology Reviews Discovery of N-Phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine Derivatives as Potent Mnk2 Inhibitors: Design, Synthesis, SAR Analysis, and Evaluation of in vitro Anti-leukaemic Activity
Medicinal Chemistry In Vivo Anticancer Activity, Toxicology and Histopathological Studies of the Thiolate Gold(I) Complex [Au(Spyrimidine)(PTA-CH<sub>2</sub>Ph)]Br
Anti-Cancer Agents in Medicinal Chemistry Engineering Antibodies for Therapy
Current Pharmaceutical Biotechnology